Structure

Physi-Chem Properties

Molecular Weight:  300.14
Volume:  319.477
LogP:  3.446
LogD:  2.769
LogS:  -4.104
# Rotatable Bonds:  0
TPSA:  63.6
# H-Bond Aceptor:  4
# H-Bond Donor:  1
# Rings:  2
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.589
Synthetic Accessibility Score:  3.902
Fsp3:  0.333
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.654
MDCK Permeability:  1.974039332708344e-05
Pgp-inhibitor:  0.0
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.025
30% Bioavailability (F30%):  0.351

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.096
Plasma Protein Binding (PPB):  98.36219787597656%
Volume Distribution (VD):  0.311
Pgp-substrate:  1.475000023841858%

ADMET: Metabolism

CYP1A2-inhibitor:  0.738
CYP1A2-substrate:  0.103
CYP2C19-inhibitor:  0.676
CYP2C19-substrate:  0.057
CYP2C9-inhibitor:  0.622
CYP2C9-substrate:  0.97
CYP2D6-inhibitor:  0.695
CYP2D6-substrate:  0.541
CYP3A4-inhibitor:  0.769
CYP3A4-substrate:  0.122

ADMET: Excretion

Clearance (CL):  7.437
Half-life (T1/2):  0.904

ADMET: Toxicity

hERG Blockers:  0.003
Human Hepatotoxicity (H-HT):  0.27
Drug-inuced Liver Injury (DILI):  0.624
AMES Toxicity:  0.639
Rat Oral Acute Toxicity:  0.033
Maximum Recommended Daily Dose:  0.74
Skin Sensitization:  0.93
Carcinogencity:  0.892
Eye Corrosion:  0.264
Eye Irritation:  0.774
Respiratory Toxicity:  0.718

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC43627

Natural Product ID:  NPC43627
Common Name*:   Monocillin Ii
IUPAC Name:   (4E,8E,11S)-15-hydroxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(14),4,8,15,17-pentaene-3,13-dione
Synonyms:   Monocillin II
Standard InCHIKey:  LSIFWWADIGESKN-UIWFPMPVSA-N
Standard InCHI:  InChI=1S/C18H20O4/c1-13-8-5-3-2-4-6-10-15(19)12-14-9-7-11-16(20)17(14)18(21)22-13/h3,5-7,9-11,13,20H,2,4,8,12H2,1H3/b5-3+,10-6+/t13-/m0/s1
SMILES:  C[C@H]1C/C=C/CC/C=C/C(=O)Cc2cccc(c2C(=O)O1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL498851
PubChem CID:   6478915
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000147] Macrolides and analogues

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO27821.1 Pochonia chlamydosporia Under-species n.a. n.a. n.a. n.a. n.a. PMID[12828470]
NPO33698 Paecilomyces sp. SC0926 Species Eukaryota n.a. Dinghu Mountain Biosphere Reserve, Guangdong, China 2003-MAR PMID[28749671]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1287 Individual Protein Cannabinoid CB2 receptor Homo sapiens Inhibition = 14.8 % PMID[526274]
NPT232 Individual Protein Cannabinoid CB1 receptor Homo sapiens Inhibition = 26.2 % PMID[526274]
NPT145 Individual Protein Mu opioid receptor Homo sapiens Inhibition = 63.5 % PMID[526274]
NPT272 Individual Protein Kappa opioid receptor Homo sapiens Inhibition = 9.0 % PMID[526274]
NPT271 Individual Protein Delta opioid receptor Homo sapiens Inhibition = -3.1 % PMID[526274]
NPT2 Others Unspecified IC50 = 7360.0 nM PMID[526273]
NPT27 Others Unspecified TC50 = 17.62 uM PMID[526273]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC43627 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9921 High Similarity NPC474097
0.9403 High Similarity NPC478201
0.9403 High Similarity NPC472035
0.9259 High Similarity NPC478217
0.9259 High Similarity NPC313123
0.9242 High Similarity NPC27407
0.9197 High Similarity NPC126882
0.9197 High Similarity NPC210966
0.9197 High Similarity NPC478203
0.9179 High Similarity NPC9121
0.9179 High Similarity NPC177307
0.9179 High Similarity NPC33144
0.9179 High Similarity NPC478200
0.913 High Similarity NPC472034
0.913 High Similarity NPC257558
0.9124 High Similarity NPC478202
0.9098 High Similarity NPC142027
0.9084 High Similarity NPC214702
0.9084 High Similarity NPC470831
0.9084 High Similarity NPC7012
0.9065 High Similarity NPC472033
0.9037 High Similarity NPC191835
0.9037 High Similarity NPC472403
0.9 High Similarity NPC472036
0.8963 High Similarity NPC474771
0.8963 High Similarity NPC474849
0.8963 High Similarity NPC70380
0.8963 High Similarity NPC65837
0.8963 High Similarity NPC149372
0.8963 High Similarity NPC71256
0.8963 High Similarity NPC178467
0.8915 High Similarity NPC167055
0.8915 High Similarity NPC240744
0.8905 High Similarity NPC158472
0.8897 High Similarity NPC94248
0.8897 High Similarity NPC475974
0.8897 High Similarity NPC221104
0.8897 High Similarity NPC212693
0.8872 High Similarity NPC470160
0.8841 High Similarity NPC158634
0.8841 High Similarity NPC470842
0.8837 High Similarity NPC91475
0.8837 High Similarity NPC265910
0.8832 High Similarity NPC52358
0.8832 High Similarity NPC92655
0.881 High Similarity NPC90522
0.881 High Similarity NPC328459
0.8806 High Similarity NPC153783
0.8777 High Similarity NPC474385
0.8759 High Similarity NPC197666
0.8759 High Similarity NPC126739
0.8759 High Similarity NPC472602
0.875 High Similarity NPC235115
0.875 High Similarity NPC291454
0.874 High Similarity NPC72977
0.873 High Similarity NPC94637
0.8714 High Similarity NPC472006
0.8714 High Similarity NPC66593
0.8712 High Similarity NPC95537
0.8705 High Similarity NPC1704
0.8705 High Similarity NPC53649
0.8705 High Similarity NPC472603
0.8705 High Similarity NPC244923
0.8705 High Similarity NPC475730
0.8705 High Similarity NPC67650
0.8696 High Similarity NPC105456
0.8696 High Similarity NPC268052
0.8696 High Similarity NPC32360
0.8696 High Similarity NPC295339
0.8696 High Similarity NPC474655
0.8696 High Similarity NPC139634
0.8686 High Similarity NPC301915
0.8686 High Similarity NPC261292
0.8682 High Similarity NPC217756
0.8672 High Similarity NPC301987
0.8672 High Similarity NPC292665
0.8672 High Similarity NPC26433
0.8672 High Similarity NPC35856
0.8672 High Similarity NPC178395
0.8672 High Similarity NPC115188
0.8672 High Similarity NPC179092
0.8672 High Similarity NPC159760
0.8672 High Similarity NPC272454
0.8672 High Similarity NPC244994
0.8672 High Similarity NPC222876
0.8671 High Similarity NPC471642
0.8671 High Similarity NPC240253
0.8671 High Similarity NPC73411
0.8671 High Similarity NPC240622
0.8671 High Similarity NPC471641
0.8671 High Similarity NPC215711
0.8667 High Similarity NPC295406
0.8667 High Similarity NPC289572
0.8667 High Similarity NPC200422
0.8667 High Similarity NPC157478
0.8661 High Similarity NPC233165
0.8661 High Similarity NPC184579
0.8657 High Similarity NPC219892
0.8657 High Similarity NPC189823
0.8652 High Similarity NPC86373
0.8652 High Similarity NPC280404
0.8652 High Similarity NPC42540
0.8652 High Similarity NPC151607
0.8652 High Similarity NPC277426
0.8652 High Similarity NPC210425
0.8651 High Similarity NPC125252
0.8636 High Similarity NPC181715
0.8633 High Similarity NPC472601
0.8633 High Similarity NPC472600
0.8623 High Similarity NPC61590
0.8601 High Similarity NPC210320
0.8593 High Similarity NPC477406
0.8592 High Similarity NPC312789
0.8592 High Similarity NPC83272
0.8582 High Similarity NPC159721
0.8582 High Similarity NPC51106
0.8582 High Similarity NPC354984
0.8571 High Similarity NPC472605
0.8571 High Similarity NPC472604
0.8571 High Similarity NPC41263
0.8571 High Similarity NPC257003
0.8571 High Similarity NPC128825
0.8561 High Similarity NPC299405
0.8561 High Similarity NPC111422
0.8561 High Similarity NPC306835
0.8561 High Similarity NPC471602
0.8561 High Similarity NPC256463
0.8561 High Similarity NPC216312
0.8561 High Similarity NPC476477
0.8561 High Similarity NPC29771
0.8552 High Similarity NPC56204
0.8551 High Similarity NPC194579
0.8551 High Similarity NPC135837
0.854 High Similarity NPC267539
0.854 High Similarity NPC229638
0.854 High Similarity NPC254832
0.854 High Similarity NPC204257
0.854 High Similarity NPC71108
0.854 High Similarity NPC176102
0.854 High Similarity NPC29317
0.8531 High Similarity NPC107625
0.85 High Similarity NPC155205
0.85 High Similarity NPC37992
0.85 High Similarity NPC32749
0.85 High Similarity NPC220496
0.85 High Similarity NPC42262
0.85 High Similarity NPC241349
0.85 High Similarity NPC327916
0.85 High Similarity NPC147542
0.8483 Intermediate Similarity NPC84142
0.8467 Intermediate Similarity NPC175943
0.8451 Intermediate Similarity NPC471731
0.8451 Intermediate Similarity NPC472610
0.8451 Intermediate Similarity NPC476473
0.8451 Intermediate Similarity NPC469542
0.8451 Intermediate Similarity NPC21873
0.845 Intermediate Similarity NPC233282
0.8444 Intermediate Similarity NPC17840
0.8444 Intermediate Similarity NPC247477
0.8444 Intermediate Similarity NPC473271
0.844 Intermediate Similarity NPC37530
0.844 Intermediate Similarity NPC149533
0.844 Intermediate Similarity NPC130485
0.844 Intermediate Similarity NPC471444
0.8429 Intermediate Similarity NPC88269
0.8425 Intermediate Similarity NPC477453
0.8425 Intermediate Similarity NPC472891
0.8425 Intermediate Similarity NPC164762
0.8414 Intermediate Similarity NPC153417
0.8409 Intermediate Similarity NPC470163
0.8409 Intermediate Similarity NPC470162
0.8406 Intermediate Similarity NPC182496
0.8406 Intermediate Similarity NPC180905
0.8403 Intermediate Similarity NPC473023
0.8397 Intermediate Similarity NPC244351
0.8397 Intermediate Similarity NPC46634
0.8397 Intermediate Similarity NPC477151
0.8397 Intermediate Similarity NPC132518
0.8394 Intermediate Similarity NPC472591
0.8392 Intermediate Similarity NPC274085
0.8392 Intermediate Similarity NPC103910
0.8392 Intermediate Similarity NPC89664
0.838 Intermediate Similarity NPC469579
0.838 Intermediate Similarity NPC471644
0.838 Intermediate Similarity NPC250755
0.838 Intermediate Similarity NPC471640
0.838 Intermediate Similarity NPC474300
0.838 Intermediate Similarity NPC471733
0.8369 Intermediate Similarity NPC168471
0.8369 Intermediate Similarity NPC315578
0.8369 Intermediate Similarity NPC99441
0.8367 Intermediate Similarity NPC91809
0.8358 Intermediate Similarity NPC71525
0.8357 Intermediate Similarity NPC4214
0.8356 Intermediate Similarity NPC476684
0.8346 Intermediate Similarity NPC287473
0.8346 Intermediate Similarity NPC262671
0.8346 Intermediate Similarity NPC4164
0.8346 Intermediate Similarity NPC201728
0.8345 Intermediate Similarity NPC14098

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC43627 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8571 High Similarity NPD9493 Approved
0.8298 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8156 Intermediate Similarity NPD2935 Discontinued
0.812 Intermediate Similarity NPD9717 Approved
0.8015 Intermediate Similarity NPD9545 Approved
0.8013 Intermediate Similarity NPD7819 Suspended
0.8 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7959 Intermediate Similarity NPD2532 Approved
0.7959 Intermediate Similarity NPD2533 Approved
0.7959 Intermediate Similarity NPD2534 Approved
0.7941 Intermediate Similarity NPD1203 Approved
0.7937 Intermediate Similarity NPD9266 Approved
0.7937 Intermediate Similarity NPD74 Approved
0.7914 Intermediate Similarity NPD411 Approved
0.7899 Intermediate Similarity NPD6832 Phase 2
0.7872 Intermediate Similarity NPD447 Suspended
0.7867 Intermediate Similarity NPD3226 Approved
0.7857 Intermediate Similarity NPD9267 Approved
0.7857 Intermediate Similarity NPD9264 Approved
0.7857 Intermediate Similarity NPD9263 Approved
0.7847 Intermediate Similarity NPD2346 Discontinued
0.7808 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7786 Intermediate Similarity NPD3268 Approved
0.7763 Intermediate Similarity NPD7411 Suspended
0.7746 Intermediate Similarity NPD230 Phase 1
0.7746 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.774 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7708 Intermediate Similarity NPD1510 Phase 2
0.7708 Intermediate Similarity NPD2799 Discontinued
0.7681 Intermediate Similarity NPD1470 Approved
0.7676 Intermediate Similarity NPD1240 Approved
0.7671 Intermediate Similarity NPD1549 Phase 2
0.7655 Intermediate Similarity NPD1551 Phase 2
0.7655 Intermediate Similarity NPD5404 Approved
0.7655 Intermediate Similarity NPD5406 Approved
0.7655 Intermediate Similarity NPD5405 Approved
0.7655 Intermediate Similarity NPD5408 Approved
0.7651 Intermediate Similarity NPD6799 Approved
0.7647 Intermediate Similarity NPD1201 Approved
0.7632 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7628 Intermediate Similarity NPD7075 Discontinued
0.7626 Intermediate Similarity NPD1019 Discontinued
0.7626 Intermediate Similarity NPD2798 Approved
0.7613 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7603 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7603 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD9281 Approved
0.7569 Intermediate Similarity NPD1607 Approved
0.7568 Intermediate Similarity NPD3750 Approved
0.7562 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7554 Intermediate Similarity NPD1164 Approved
0.7548 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7548 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.754 Intermediate Similarity NPD9261 Approved
0.7538 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7535 Intermediate Similarity NPD3764 Approved
0.7535 Intermediate Similarity NPD2313 Discontinued
0.7534 Intermediate Similarity NPD2796 Approved
0.7519 Intermediate Similarity NPD2182 Approved
0.7484 Intermediate Similarity NPD1934 Approved
0.7483 Intermediate Similarity NPD520 Approved
0.7483 Intermediate Similarity NPD2344 Approved
0.7483 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD6599 Discontinued
0.7468 Intermediate Similarity NPD4380 Phase 2
0.7452 Intermediate Similarity NPD3882 Suspended
0.745 Intermediate Similarity NPD4628 Phase 3
0.7438 Intermediate Similarity NPD6232 Discontinued
0.7431 Intermediate Similarity NPD943 Approved
0.7429 Intermediate Similarity NPD3267 Approved
0.7429 Intermediate Similarity NPD2797 Approved
0.7429 Intermediate Similarity NPD3266 Approved
0.7407 Intermediate Similarity NPD7473 Discontinued
0.7405 Intermediate Similarity NPD3749 Approved
0.7391 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD5402 Approved
0.7389 Intermediate Similarity NPD3817 Phase 2
0.7386 Intermediate Similarity NPD5403 Approved
0.7381 Intermediate Similarity NPD8150 Discontinued
0.7375 Intermediate Similarity NPD6959 Discontinued
0.7372 Intermediate Similarity NPD6801 Discontinued
0.7372 Intermediate Similarity NPD4626 Approved
0.7347 Intermediate Similarity NPD4308 Phase 3
0.7342 Intermediate Similarity NPD7768 Phase 2
0.7325 Intermediate Similarity NPD2801 Approved
0.7319 Intermediate Similarity NPD3496 Discontinued
0.7308 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD1511 Approved
0.7303 Intermediate Similarity NPD7390 Discontinued
0.7299 Intermediate Similarity NPD5691 Approved
0.7299 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD2309 Approved
0.726 Intermediate Similarity NPD1933 Approved
0.7255 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD5401 Approved
0.7255 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD1471 Phase 3
0.7246 Intermediate Similarity NPD1778 Approved
0.7233 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.723 Intermediate Similarity NPD3748 Approved
0.723 Intermediate Similarity NPD7033 Discontinued
0.7222 Intermediate Similarity NPD5710 Approved
0.7222 Intermediate Similarity NPD5711 Approved
0.7219 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD7003 Approved
0.7219 Intermediate Similarity NPD8166 Discontinued
0.7214 Intermediate Similarity NPD1608 Approved
0.7212 Intermediate Similarity NPD5844 Phase 1
0.7209 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD164 Approved
0.7208 Intermediate Similarity NPD1512 Approved
0.7208 Intermediate Similarity NPD6273 Approved
0.7203 Intermediate Similarity NPD9494 Approved
0.7179 Intermediate Similarity NPD7458 Discontinued
0.7152 Intermediate Similarity NPD3818 Discontinued
0.7134 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD6166 Phase 2
0.7134 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD5647 Approved
0.7133 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD6663 Approved
0.7117 Intermediate Similarity NPD6808 Phase 2
0.7113 Intermediate Similarity NPD3225 Approved
0.7113 Intermediate Similarity NPD1283 Approved
0.7108 Intermediate Similarity NPD7054 Approved
0.7103 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD8313 Approved
0.7101 Intermediate Similarity NPD8312 Approved
0.7092 Intermediate Similarity NPD3972 Approved
0.7092 Intermediate Similarity NPD9269 Phase 2
0.7089 Intermediate Similarity NPD5889 Approved
0.7089 Intermediate Similarity NPD5890 Approved
0.7083 Intermediate Similarity NPD5736 Approved
0.7075 Intermediate Similarity NPD4060 Phase 1
0.7075 Intermediate Similarity NPD4307 Phase 2
0.707 Intermediate Similarity NPD3455 Phase 2
0.7067 Intermediate Similarity NPD6100 Approved
0.7067 Intermediate Similarity NPD6099 Approved
0.7066 Intermediate Similarity NPD7074 Phase 3
0.7066 Intermediate Similarity NPD7472 Approved
0.7059 Intermediate Similarity NPD6190 Approved
0.7055 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD920 Approved
0.705 Intermediate Similarity NPD9268 Approved
0.7044 Intermediate Similarity NPD6844 Discontinued
0.7041 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD2800 Approved
0.7039 Intermediate Similarity NPD1243 Approved
0.7027 Intermediate Similarity NPD6355 Discontinued
0.7024 Intermediate Similarity NPD5953 Discontinued
0.7024 Intermediate Similarity NPD6797 Phase 2
0.7013 Intermediate Similarity NPD7236 Approved
0.7013 Intermediate Similarity NPD3300 Phase 2
0.7013 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD17 Approved
0.7 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.6994 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6994 Remote Similarity NPD5494 Approved
0.6993 Remote Similarity NPD1876 Approved
0.6986 Remote Similarity NPD7008 Discontinued
0.6985 Remote Similarity NPD1241 Discontinued
0.6982 Remote Similarity NPD7251 Discontinued
0.6982 Remote Similarity NPD6559 Discontinued
0.698 Remote Similarity NPD6653 Approved
0.698 Remote Similarity NPD6651 Approved
0.6963 Remote Similarity NPD1609 Clinical (unspecified phase)
0.6962 Remote Similarity NPD2651 Approved
0.6962 Remote Similarity NPD2649 Approved
0.6959 Remote Similarity NPD2979 Phase 3
0.6954 Remote Similarity NPD4477 Approved
0.6954 Remote Similarity NPD4476 Approved
0.6954 Remote Similarity NPD2438 Suspended
0.6946 Remote Similarity NPD7177 Discontinued
0.6941 Remote Similarity NPD7808 Phase 3
0.6939 Remote Similarity NPD6798 Discontinued
0.6934 Remote Similarity NPD690 Clinical (unspecified phase)
0.6933 Remote Similarity NPD919 Approved
0.6923 Remote Similarity NPD642 Clinical (unspecified phase)
0.6918 Remote Similarity NPD6585 Discontinued
0.6908 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6908 Remote Similarity NPD6004 Phase 3
0.6908 Remote Similarity NPD6005 Phase 3
0.6908 Remote Similarity NPD6002 Phase 3
0.6908 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6905 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6905 Remote Similarity NPD7286 Phase 2
0.6901 Remote Similarity NPD1281 Approved
0.6899 Remote Similarity NPD1238 Approved
0.6894 Remote Similarity NPD1465 Phase 2
0.6879 Remote Similarity NPD3019 Approved
0.6879 Remote Similarity NPD2932 Approved
0.6875 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6875 Remote Similarity NPD6213 Phase 3
0.6875 Remote Similarity NPD6212 Phase 3
0.687 Remote Similarity NPD6647 Phase 2
0.6866 Remote Similarity NPD6831 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data